Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Carotid Artery Disease Companies

Carotid artery disease refers to the narrowing or blockage of the carotid arteries, which are major blood vessels that supply oxygenated blood to the brain. Various companies are involved in developing technologies and treatments related to carotid artery disease.

Carotid Artery Disease Key Companies Latest Carotid Artery Disease Treatment Companies Update

August 2022: Following recent CE Mark approval, Medtronic announced the introduction of its newest drug-eluting coronary stent, the Onyx Frontier drug-eluting stent (DES). The Onyx Frontier drug-eluting stent (DES) presents a novel delivery system that extends the capabilities and clinical insights established with the Resolute Onyx DES. Utilizing the identical best-in-class stent platform as Resolute Onyx DES, the DES augments acute efficacy and deliverability in the most difficult cases through an improved delivery system. Significant design modifications of the Onyx Frontier DES, such as an innovative dual-layer balloon, a reduced crossing profile, and enhanced catheter flexibility, resulted in a 16% enhancement in deliverability when compared to the Resolute Onyx DES of the previous iteration. Moreover, radial strength was not compromised. Resolute Onyx's clinical data and indications are carried over to Onyx Frontier, including approval for left main PCI, bifurcation lesions, and one month of dual antiplatelet therapy (DAPT) in patients at high risk of hemorrhage.

May 2023: A prominent provider from India, Dr. Reddy's Laboratories Ltd., has introduced Regadenoson Injection to the U.S. market. The generic therapeutic equivalent of Lexiscan (Regadenoson) injection, which has received approval from the U.S. Food and Drug Administration (USFDA), is available. As per the press release issued by the organization, Dr. Reddy's Regadenoson Injection is available in pre-filled single-dose syringes containing 0.4 mg/5 mL (0.08 mg/mL). The purpose of this injection is to diagnose coronary artery disease in the heart. It is administered to patients who are unable to exercise for their stress test, per health professionals. As per the Mayo Clinics, this medication aids in the detection of coronary artery disease by dilatation of the coronary arteries and elevation of blood flow.

List of Carotid Artery Disease Treatment Key companies in the market

Medtronic Plc

Pfizer

GE Healthcare

Cardinal Health

Eli Lily and Company

AdvanceCor GmbH

Teleflex, Siemens Healthcare

Daiichi Sankyo Co. Ltd.

Abbot Laboratories

Bristol-Myers Squibb

Merck & Cp. Inc.

Silk Road Medical

Stryker Corporation

Carotid Artery Disease Market Highlights:

Carotid Artery Disease Market Size

Carotid Artery Disease Market Trends

Carotid Artery Disease Market Analysis

Carotid Artery Disease Market Share

Carotid Artery Disease Market Highlights:

Carotid Artery Disease Market Trends

Carotid Artery Disease Market Analysis

Carotid Artery Disease Market Share

Carotid Artery Disease Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.